Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Scandinavian Journal of Rheumatology

• Publication date

  2018-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/03009742.2017.1287305PMID 28303752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis

  2016cited by this paper
• Ankylosis in ankylosing spondylitis: current concepts

  2015cited by this paper
• Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis

  2014cited by this paper
• Wnt signaling in ankylosing spondylitis

  2014cited by this paper
• NSAIDs can have adverse effects on bone healing.

  2013cited by this paper
• Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review.

  2013cited by this paper
• Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy

  2012cited by this paper
• Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

  2012cited by this paper
• Osteo-Rheumatology: a new discipline?

  2012cited by this paper
• NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?

  2012cited by this paper
• Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

  2012cited by this paper
• The balance of tissue repair and remodeling in chronic arthritis

  2011cited by this paper
• Imaging of axial spondyloarthritis including ankylosing spondylitis

  2011cited by this paper
• Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.

  2010cited by this paper
• Association of Bone Morphogenetic Proteins with Spinal Fusion in Ankylosing Spondylitis

  2010cited by this paper
• Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints

  2009cited by this paper
• Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis

  2009cited by this paper
• Inflammation and destruction of the joints--the Wnt pathway.

  2008cited by this paper
• The use of bone morphogenetic protein in spine fusion.

  2008cited by this paper
• Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis

  2008cited by this paper
• Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.

  2007cited by this paper
• Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis.

  2007cited by this paper
• Bone morphogenetic proteins in destructive and remodeling arthritis

  2007cited by this paper
• Dickkopf-1 is a master regulator of joint remodeling

  2007influential reference
• Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.

  2007cited by this paper
• Nonsteroidal Anti-Inflammatory Drug Effects on Osteoblastic Cell Cycle, Cytotoxicity, and Cell Death

  2005cited by this paper
• Bone morphogenetic protein signaling in joint homeostasis and disease.

  2005cited by this paper
• The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.

  2005cited by this paper
• Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.

  2005cited by this paper
• Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.

  2005cited by this paper
• Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

  2005cited by this paper
• Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

  2004cited by this paper
• of Disease Modification in Spondyloarthropathy

  2004cited by this paper
• International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

  2003cited by this paper
• The concept of disease modification in spondyloarthropathy.

  2002cited by this paper
• Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing

  2002cited by this paper
• COX‐2 selective NSAID decreases bone ingrowth in vivo

  2002cited by this paper
• A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index.

  1999cited by this paper
• The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

  1996cited by this paper
• A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

  1994cited by this paper
• A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

  1994cited by this paper
• Ankylosing spondylitis and other spondyloarthropathies.

  1990cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper
• Bone: Formation by Autoinduction

  1965cited by this paper

• Bone Mineral Density and Serum Levels of Bone Remodeling Markers in Ankylosing Spondylitis Treated with Anti TNF-α Agents

  2025cites this paper
• Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings

  2024cites this paper
• Axial Spondyloarthritis: an overview of the disease

  2024cites this paper
• Novel DNA Aptamers to Dickkopf-1 Protein and Their Application in Colorimetric Sandwich Assays for Target Detection in Patients with Axial Spondyloarthritis

  2024cites this paper
• Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis – SPARTAN 2024 Annual Meeting Proceedings

  2024cites this paper
• Aberrant DNA Methylation Profile of Dickkopf-1 in Ankylosing Spondylitis

  2024cites this paper
• Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization

  2023cites this paper
• Osteoimmunology of Spondyloarthritis

  2023cites this paper
• Serum concentration of dickkopf-related protein 1 (DKK1) in psoriatic arthritis in the context of bone remodelling

  2023cites this paper
• DNA methylation of DKK‐1 may correlate with pathological bone formation in ankylosing spondylitis

  2023cites this paper
• Serum level of bone morphogenetic protein-7 in relation to entheseal ultrasonography in ankylosing spondylitis patients

  2022cites this paper
• Axial spondyloarthritis - from inflammation to ankylosis

  2022cites this paper
• Dickkopf-1 as a promising therapeutic target for autoimmune diseases.

  2022cites this paper
• Clinical Diagnostic Value of Dkk-1 Level in Ankylosing Spondylitis: Comparison of Test Systems Based on Aptamers and Antibodies

  2022cites this paper
• Dickkopf-1 directs periosteal bone formation in two murine models of inflammatory arthritis

  2022cites this paper
• The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis

  2022cites this paper
• Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis

  2022influential citation
• Effect of Warming Yang, Tonifying Kidney, and Removing Arthralgia Therapy on Cold-Dampness Arthralgia Type Ankylosing Spondylitis and Its Influence on the Levels of Humoral Factor in Human Serum

  2022cites this paper
• Advances in bone turnover markers.

  2021cites this paper
• Cytokine “fine tuning” of enthesis tissue homeostasis as a pointer to spondyloarthritis pathogenesis with a focus on relevant TNF and IL-17 targeted therapies

  2021cites this paper
• Osteoimmunological insights into the pathogenesis of ankylosing spondylitis

  2021cites this paper
• The Effects of Sex and Estrogen on Radiographic Progression of Ankylosing Spondylitis in Korean Patients

  2021influential citation
• Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review

  2021influential citation
• The TNF-NF-kB-DKK1 Axis Promoted Bone Formation in the Enthesis of Ankylosing Spondylitis

  2021cites this paper
• Progression of axial spondyloarthritis

  2021cites this paper
• Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features?

  2020cites this paper
• Enhanced BMP-2/BMP-4 ratio in patients with peripheral spondyloarthritis and in cytokine- and stretch-stimulated mouse chondrocytes

  2020cites this paper
• Changes in bone formation regulator biomarkers in early axial spondyloarthritis.

  2020cites this paper
• Clinical significance and prognostic value of tumor necrosis factor-α and dickkopf related protein-1 in ankylosing spondylitis.

  2020cites this paper
• Pathogenesis of Ankylosing Spondylitis

  2019cites this paper
• Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study.

  2019cites this paper
• Serum Sclerostin and Bone Morphogenetic Protein-2 Levels in Patients with Ankylosing Spondylitis: A Meta-Analysis

  2019cites this paper
• miR-17-5p Regulates Heterotopic Ossification by Targeting ANKH in Ankylosing Spondylitis

  2019cites this paper
• Genetic polymorphism of BMP-6 gene ( rs 267196 and rs 267192 ) in patients with ankylosing spondylitis Ankilozan spondilitli hastalarda BMP-6 ( rs 267196 ve rs 267192 ) genetik polimorfizmi

  2019cites this paper
• Association study of copy number variation in BMP8A gene with the risk of ankylosing spondylitis in Iranian population

  2018cites this paper
• The transgenic Drosophila HLA-B27 : a new model for the study of spondyloarthritis

  2018cites this paper
• Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis

  2018cites this paper
• Autoimmune Diseases have a Strong Genetic Basis, such as HLAB27 in Ankylosing Spondylitis

  2017cites this paper